<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02356666</url>
  </required_header>
  <id_info>
    <org_study_id>1817118</org_study_id>
    <nct_id>NCT02356666</nct_id>
  </id_info>
  <brief_title>Prevalence of Nocturnal Hypoventilation in Neuromuscular Diseases According to Different Definitions</brief_title>
  <acronym>TcCO2</acronym>
  <official_title>Prevalence of Nocturnal Hypoventilation in Neuromuscular Diseases According to Different Definitions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre d'Investigation Clinique et Technologique 805</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre d'Investigation Clinique et Technologique 805</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Different definitions of nocturnal hypoventilation are used in the recent literature. The
      investigators aimed to compare the prevalence of nocturnal hypoventilation in a neuromuscular
      disease's population according to different definitions issued from the literature.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Different definitions of nocturnal hypoventilation are used in the recent literature. Basing
      on retrospective data review, we aimed to compare the prevalence of nocturnal hypoventilation
      in the cohort of neuromuscular disease's patients followed at our reference center, according
      to different definitions issued from the literature.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Differences in the prevalence of nocturnal hypoventilation according to different previously proposed definitions</measure>
    <time_frame>Baseline (Day 1)</time_frame>
    <description>The prevalence of nocturnal hypoventilation (percentage of patients diagnosed as having hypoventilation over the total population) according to the different definition available in the literature will be described</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Concordance between the diagnostic criteria</measure>
    <time_frame>Baseline (Day 1)</time_frame>
    <description>Concordance between the different diagnostic criteria of hypoventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sensibility/specificity of the different criteria to identify daytime alveolar hypoventilation (defined on blood gas analysis)</measure>
    <time_frame>Baseine (Day 1)</time_frame>
    <description>sensibility/specificity of the different criteria to identify daytime alveolar hypoventilation (defined on blood gas analysis)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prognostic value of the different definitions of nocturnal hypoventilation</measure>
    <time_frame>5 years</time_frame>
    <description>The ability of the examined definition to predict the need for mechanical ventilation will be investigated, defined as appearance of daytime hypercapnia or beginning of mechanical ventilation and/or mortality.</description>
  </secondary_outcome>
  <enrollment type="Actual">232</enrollment>
  <condition>Neuromuscular Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Neuromuscular disease
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Neuromuscular disease

          -  Age ≥18 years

          -  Non mechanically ventilated

        Exclusion Criteria:

          -  Long-term oxygen therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adam Ogna, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hopital Raymond Poincare</name>
      <address>
        <city>Garches</city>
        <zip>92380</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2014</study_first_submitted>
  <study_first_submitted_qc>February 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 5, 2015</study_first_posted>
  <last_update_submitted>February 25, 2016</last_update_submitted>
  <last_update_submitted_qc>February 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuromuscular Diseases</mesh_term>
    <mesh_term>Hypoventilation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

